Eulexin
$138.60
1000 in stock
Eulexin is indicated for use in combination with LHRH agonists for the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate.
$138.60
1000 in stock
Eulexin is indicated for use in combination with LHRH agonists for the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate.
Reviews
There are no reviews yet.